Linda Sharples | Academic Influence

Linda Sharples's AcademicInfluence.com Rankings

Linda Sharples

Computer Science

#10742

World Rank

#11300

Historical Rank

Machine Learning

#4899

World Rank

#4956

Historical Rank

Artificial Intelligence

#5269

World Rank

#5340

Historical Rank

Database

#7715

World Rank

#8019

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Linda Sharples's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Linda Sharples Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Linda Sharples is a British statistician who is Professor of Medical Statistics at the London School of Hygiene & Tropical Medicine. Her research considers statistical analysis of medical interventions. She has provided expert advice to clinical trials on cardiovascular disease, diabetes and cancer.

(See a Problem?)

Linda Sharples's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching (2005) (455)
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial (2009) (389)
Risk factors for bronchiolitis obliterans: a systematic review of recent publications. (2002) (339)
Multistate Markov models for disease progression with classification error (2003) (307)
Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. (1998) (305)
Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. (2016) (221)
Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension (1998) (204)
Modelling Complexity: Applications of Gibbs Sampling in Medicine (1993) (203)
Assessment of survival benefit after lung transplantation by patient diagnosis. (2002) (196)
Idiopathic hypersomnia: a study of 77 cases. (2007) (186)
Flexible random‐effects models using Bayesian semi‐parametric models: applications to institutional comparisons (2007) (185)
Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome (2017) (182)
Performance status score: do patients and their oncologists agree? (2003) (180)
Prospective study of quality of life before and after coronary artery bypass grafting. (1991) (172)
Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors. (1996) (162)
Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus. (2013) (161)
Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial (2014) (161)
Outcome of elective prostatectomy. (1989) (160)
Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea (2015) (150)
Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial (2011) (140)
Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data (2014) (121)
Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer (2005) (113)
Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial. (2012) (111)
Diagnostic accuracy of coronary angiography and risk factors for post–heart-transplant cardiac allograft vasculopathy (2003) (110)
Effect of lung cancer surgery on quality of life (2005) (104)
Cardiopulmonary exercise tests and lung cancer surgical outcome. (2005) (103)
Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients (2002) (97)
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension (2012) (94)
Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. (2007) (92)
Are Stentless Valves Superior to Modern Stented Valves?: A Prospective Randomized Trial (2006) (91)
Accounting for uncertainty in health economic decision models by using model averaging (2009) (91)
Time to Cardiac Death After Withdrawal of Life‐Sustaining Treatment in Potential Organ Donors (2009) (87)
The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. (2005) (87)
Predicting HLA Class I Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid Polymorphisms (2009) (85)
Predicting HLA Class II Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid Polymorphisms (2011) (83)
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. (2006) (81)
Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy (2017) (80)
A Framework for Addressing Structural Uncertainty in Decision Models (2011) (80)
A randomised controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic (2002) (76)
Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? (2001) (76)
A Randomized Controlled Trial of Cell Salvage in Routine Cardiac Surgery (2008) (75)
Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods (2016) (74)
Predicting the Immunogenicity of Human Leukocyte Antigen Class I Alloantigens Using Structural Epitope Analysis Determined by HLAMatchmaker (2008) (74)
Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. (1993) (73)
Relationship between pulmonary function and lung cancer surgical outcome (2005) (72)
A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO) (2014) (72)
Inflammatory related changes in bone mineral content in adults with cystic fibrosis (2004) (71)
A systematic review and meta‐analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years (2019) (70)
Octogenarians undergoing cardiac surgery outlive their peers: a case for early referral (2005) (69)
Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? (2006) (69)
The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. (2002) (67)
Model diagnostics for multi-state models (2010) (64)
An Exploratory Cohort Study Comparing Prothrombin Complex Concentrate and Fresh Frozen Plasma for the Treatment of Coagulopathy After Complex Cardiac Surgery (2015) (64)
Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. (1991) (64)
Prospective study of health related quality of life before and after coronary artery bypass grafting: outcome at five years (1999) (64)
Semi‐Markov Models with Phase‐Type Sojourn Distributions (2010) (63)
A hierarchical modelling framework for identifying unusual performance in health care providers (2007) (62)
Multi-state modelling of repeated hospitalisation and death in patients with heart failure: The use of large administrative databases in clinical epidemiology (2017) (60)
The contribution of the anaesthetist to risk‐adjusted mortality after cardiac surgery† (2015) (59)
Heart and lung transplantation for terminal cystic fibrosis. A 4 1/2-year experience. (1991) (58)
Ten-Year Experience of Selective Omission of the Pretransplant Crossmatch Test in Deceased Donor Kidney Transplantation (2010) (56)
Evaluation of the ventricular assist device programme in the UK. (2006) (56)
Measurement of health-related quality of life before and after heart-lung transplantation. (1996) (55)
A case-control analysis of readmissions to the cardiac surgical intensive care unit. (2002) (54)
Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK). (2006) (53)
Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-term outcomes from the CECaT randomised controlled tr (2014) (53)
Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation. (2014) (53)
A general goodness‐of‐fit test for Markov and hidden Markov models (2008) (52)
Pulmonary endarterectomy: outcomes in patients aged >70. (2012) (51)
Right Ventricular Reverse Remodeling after Pulmonary Endarterectomy: Magnetic Resonance Imaging and Clinical and Right Heart Catheterization Assessment (2014) (51)
Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions (2009) (50)
Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: A cardiovascular magnetic resonance study. (2016) (50)
Interventions in randomised controlled trials in surgery: issues to consider during trial design (2015) (50)
Swan-Ganz catheter assessment of donor hearts: outcome of organs with borderline hemodynamics. (2001) (49)
Prospective study comparing quality of life before and after heart transplantation. (1990) (49)
Bronchiolitis Obliterans Syndrome (2012) (49)
Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. (2013) (49)
Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective (2013) (48)
EuroSCORE II and the art and science of risk modelling. (2013) (48)
Structural and parameter uncertainty in Bayesian cost-effectiveness models (2010) (48)
Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension (2007) (47)
Preoperative risk prediction and intraoperative events in cardiac surgery. (2002) (47)
Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure. (2014) (46)
The use of hospital admission data as a measure of outcome in clinical studies of heart failure. (2003) (46)
Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease (2010) (45)
Survival Models in Health Economic Evaluations: Balancing Fit and Parsimony to Improve Prediction (2010) (43)
Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy. (2010) (42)
Donor kidney disease and transplant outcome for kidneys donated after cardiac death (2009) (41)
Heart and lung transplantation for terminal cystic fibrosis: A 4½-year experience (1991) (41)
Malignancy after Heart Transplantation: Analysis of 24‐Year Experience at a Single Center (2009) (40)
Predicting Survival in Potentially Curable Lung Cancer Patients (2008) (39)
Use of the Gibbs sampler to estimate transition rates between grades of coronary disease following cardiac transplantation. (1993) (38)
Assessment of learning curves in complex surgical interventions: a consecutive case-series study (2016) (37)
Impact of the anesthesiologist and surgeon on cardiac surgical outcomes. (2014) (37)
Mini‐Stern Trial: A randomized trial comparing mini‐sternotomy to full median sternotomy for aortic valve replacement (2018) (37)
Early clinical and hemodynamic outcomes after stented and stentless aortic valve replacement: results from a randomized controlled trial. (2007) (37)
Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the Week. (2019) (36)
Point-of-Care Assessment of Hypothermia and Protamine-Induced Platelet Dysfunction with Multiple Electrode Aggregometry (Multiplate®) in Patients Undergoing Cardiopulmonary Bypass (2013) (36)
Double-Blind, Randomised, Controlled Trial Assessing Controller Medications in Asthma (2006) (35)
Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation. (2003) (35)
Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies. (2005) (35)
Calibration of Complex Models through Bayesian Evidence Synthesis (2015) (35)
The relationship between three-dimensional knee MRI bone shape and total knee replacement—a case control study: data from the Osteoarthritis Initiative (2016) (34)
Risk factors for the development and progression of dyslipidemia after heart transplantation (2002) (34)
Percutaneous myocardial laser revascularization in patients with refractory angina pectoris. (2003) (34)
Brain death leads to abnormal contractile properties of the human donor right ventricle. (2006) (33)
Microsimulation and clinical outcomes analysis support a lower age threshold for use of biological valves (2010) (32)
Life-Years Gained by Reducing Donor Heart Ischemic Times (2009) (31)
Comparison of outcomes from smoking and nonsmoking donors: thirteen-year experience. (2010) (31)
Effect of individual patient risk, centre, surgeon and anaesthetist on length of stay in hospital after cardiac surgery: Association of Cardiothoracic Anaesthesia and Critical Care (ACTACC) consecutive cases series study of 10 UK specialist centres (2017) (30)
A randomised controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic. (2002) (30)
Bayesian regression discontinuity designs: incorporating clinical knowledge in the causal analysis of primary care data (2014) (30)
An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. (2006) (30)
Experiences of Structured Elicitation for Model-Based Cost-Effectiveness Analyses (2018) (29)
Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: review of 200 patients. (2010) (28)
Short- and long-term outcomes of using pulmonary allograft donors with low Po2. (2005) (28)
A randomized controlled trial of follow-up of patients discharged from the hospital following acute asthma: best performed by specialist nurse or doctor? (2006) (27)
Identification and accommodation of outliers in general hierarchical models (1990) (27)
Survival extrapolation using the poly-Weibull model (2015) (27)
Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients (1999) (27)
Association of α1-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis (2001) (26)
Bayesian evidence synthesis to extrapolate survival estimates in cost‐effectiveness studies (2006) (26)
A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris. (2001) (25)
A model for analyzing the cost of main clinical events after cardiac transplantation. (1996) (24)
Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial (2019) (23)
The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug (2014) (23)
Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation (2002) (22)
Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK). (2007) (22)
Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome (2015) (21)
HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation. (2010) (20)
Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. (2018) (20)
A Randomized Controlled Trial of Follow-up of Patients Discharged From the Hospital Following Acute Asthma (2006) (20)
Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression. (1992) (19)
Does heart transplantation confer survival benefit in all risk groups? (2005) (19)
Models for longitudinal data with censored changepoints (2004) (18)
Contemporary roles of registries in clinical cardiology: when do we need randomized trials? (2014) (18)
Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization. (2001) (17)
A model for analyzing the cost of the main clinical events after lung transplantation. (2001) (17)
The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency. (2005) (17)
Donor Type Does Not Influence the Incidence of Major Urologic Complications After Kidney Transplantation (2010) (16)
Coronary stent length predicts PCI-induced cardiac myonecrosis (2010) (16)
Use of a Structured Mirrors Intervention Does Not Reduce Delirium Incidence But May Improve Factual Memory Encoding in Cardiac Surgical ICU Patients Aged Over 70 Years: A Pilot Time-Cluster Randomized Controlled Trial (2016) (15)
Survival extrapolation in the presence of cause specific hazards (2015) (15)
MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertain (2019) (14)
Identifying the research priorities of healthcare professionals in UK vascular surgery: modified Delphi approach (2020) (14)
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis. (2011) (13)
Comparison of survival by allocation to medical therapy, surgery, or heart transplantation for ischemic advanced heart failure. (2005) (13)
Heart surgery in UK patients: planned care or crisis management? (1996) (12)
Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation. (2018) (12)
Cystic fibrosis: a new challenge for cardiothoracic surgery. (1990) (12)
Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris (2005) (12)
A piecewise-homogeneous Markov chain process of lung transplantation. (2001) (12)
Non-parametric frailty Cox models for hierarchical time-to-event data (2018) (11)
State selection in Markov models for panel data with application to psoriatic arthritis (2015) (11)
Effect of the full implementation of the European Working Time Directive on operative training in adult cardiac surgery. (2014) (11)
The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials (2017) (11)
Evaluation of the effects of multiple providers in complex surgical interventions (2016) (10)
Bronchiolitis obliterans syndrome (BOS) following heart‐lung transplantation (1996) (10)
Multiple Interventions for Diabetic Foot Ulcer Treatment Trial (MIDFUT): study protocol for a randomised controlled trial (2020) (10)
Dynamic survival prediction combining landmarking with a machine learning ensemble: Methodology and empirical comparison (2020) (10)
Logistic regression and machine learning predicted patient mortality from large sets of diagnosis codes comparably. (2020) (10)
The role of facemask spirometry in motor neuron disease (2012) (9)
The risk model of choice for coronary surgery in the UK (2003) (9)
Analyse transplant outcomes in distinct epochs of follow-up (2006) (8)
Cystic fibrosis: lung transplantation. A new option--a new dilemma! (1992) (8)
Response to Letters Regarding Article, “Cardiac Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial” (2009) (8)
Developing a reference protocol for expert elicitation in healthcare decision making (2019) (8)
Probabilistic linkage without personal information successfully linked national clinical datasets (2021) (7)
Knowledge of pancreatic enzyme supplementation in adult cystic fibrosis (CF) patients (2000) (7)
Lung-volume reduction (2001) (7)
Recovery of Left Atrial Contractile Function After Maze Surgery in Persistent Longstanding Atrial Fibrillation. (2017) (7)
Does the "Weekend Effect" for Postoperative Mortality Stand Up to Scrutiny? Association for Cardiothoracic Anesthesia and Critical Care Cohort Study of 110,728 Cardiac Surgical Patients. (2018) (7)
Reference Case Methods for Expert Elicitation in Health Care Decision Making (2021) (6)
Response to comments on "Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea". (2016) (6)
Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation† (2018) (6)
Editorial comment: Pride without prejudice: EuroSCORE II, the STS score and the high-risk patient subset. (2013) (6)
The ETTAA study protocol: a UK-wide observational study of ‘Effective Treatments for Thoracic Aortic Aneurysm’ (2015) (6)
The use of heart-lung transplantation in management of terminal respiratory complications of cystic fibrosis. (1990) (5)
Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275] (2006) (5)
Immunologic mechanisms underlying bronchiolitis obliterans (2000) (5)
Expression of endothelial adhesion molecules and thrombomodulin in cardiac transplantation (2002) (5)
Systematic review of endovascular stent grafting versus open surgical repair for the elective treatment of arch/descending thoracic aortic aneurysms (2021) (5)
The role of statistics in the era of big data: Electronic health records for healthcare research (2018) (5)
Reply to Hickey and Bridgewater. (2013) (4)
Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results (2020) (4)
Multicentre randomised double blind placebo controlled trial assessing the effect of weekly risedronate on bone mineral density in adults with cystic fibrosis (2010) (4)
Quality of life before and after heart transplantation (1992) (4)
Effect of receiving a heart transplant (2001) (4)
Health technology assessment: TMR trials and tribulations (1996) (4)
108: Evaluation of the ventricular assist device programme in the United Kingdom (2006) (4)
Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies (2020) (4)
ResearchMapping of the EQ-5 D index from clinical outcome measures and demographic variables in patients with coronary heart disease (2010) (3)
A study to assess changes in myocardial perfusion after treatment with spinal cord stimulation and percutaneous myocardial laser revascularisation; data from a randomised trial (2008) (3)
Erratum to: Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling (2017) (3)
Protocol for an observational study evaluating new approaches to modelling diagnostic information from large administrative hospital datasets (2019) (3)
The Impact of Anesthesiologists on Coronary Artery Bypass Graft Outcomes. (2016) (3)
Exploring mechanisms of action in clinical trials of complex surgical interventions using mediation analysis (2020) (3)
Evaluating the effect of healthcare providers on the clinical path of heart failure patients through a semi-Markov, multi-state model (2020) (3)
Against the odds: long-term outcome of drastic-risk cardiac surgery. (2006) (3)
Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling (2017) (3)
Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis. (2020) (3)
A novel approach selected small sets of diagnosis codes with high prediction performance in large healthcare datasets. (2020) (3)
Development and evaluation of the critical care practitioner role. (2002) (3)
Reply to Nezic et al. (2013) (3)
Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction (2020) (2)
8: The potential impact of reducing cold ischaemic time on cardiac transplant survival (2007) (2)
Biomarkers of Disease: Statistical approaches to rational biomarker selection (2002) (2)
Systolic and diastolic dyssynchrony are unaffected by revascularization of viable, dysfunctional myocardium. (2008) (2)
Twenty-five years of heart transplantation at Papworth Hospital: Changes in factors influencing short- and long-term patient survival over time (2008) (2)
Nonparametric shared frailty model for classification of survival data (2017) (2)
British trial of transmyocardial revascularisation is continuing (1998) (2)
Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? (2001) (2)
Power and sample size for multistate model analysis of longitudinal discrete outcomes in disease prevention trials (2021) (2)
Misinterpretation of published results. (1994) (1)
The Ethics of Domino Heart Transplantation (1991) (1)
Reply to Collins and Altman. (2013) (1)
Coronary care unit ST-trending system: interpreting complex output data. (1995) (1)
Epworth Sleepiness Scale (2014) (1)
Including random centre effects in design, analysis and presentation of multi-centre trials (2021) (1)
Randomised controlled trial of mandibular advancement devices for obstructive sleep apnoea (TOMADO): one year follow-up (2014) (1)
Methods of analysis for survival outcomes with time-updated mediators, with application to longitudinal disease registry data (2022) (1)
Impact of changes to the interscreening interval and faecal immunochemical test threshold in the national bowel cancer screening programme in England: results from the FIT pilot study (2022) (1)
Bayesian analysis of trial-based cost-effectiveness in the presence of missing data: effects of including covariates on efficiency of estimation in the ASTER trial (2011) (1)
Report of the Editors (2014) (1)
Diagnostic accuracy of coronary angiography and risk factors for post-heart transplant Coronary Artery Vasculopathy (CAV) (2003) (1)
Survival benefit of heart transplantation in high risk donors and recipients (2003) (1)
244 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial (2019) (1)
This is a repository copy of Extrapolating survival from randomised trials using external data : a review of methods (2019) (1)
The randomised, controlled, crossover Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (2014) (1)
404: Twenty-five years of heart transplantation at a single centre: Changes in factors influencing short- and long-term survival over time (2007) (1)
Adverse event specific tables (2014) (0)
Systematic review and meta-analysis of trials of treatments for sleep apnoea–hypopnoea (2014) (0)
Short and long term outcomes using marginal pulmonary allograft donors (2003) (0)
Summary of resource use costs valued in 2011/12 British pounds sterling (2014) (0)
964-13 Continuous Infusion of Prostacyclln (PGI2) Improves Survival in Severe Pulmonary Hypertension (1995) (0)
Differences in Short Form questionnaire-6 Dimensions quality-adjusted life-years for each treatment compared with control (2014) (0)
Is pulmonary endarterectomy (PEA) beneficial for the elderly? An analysis of quality of life (QoL) outcomes for older patients (2013) (0)
TRANSMYOCARDLAL LASER REVASCULARISATION IN CLINICAL PRACTICE. AUTHORS' REPLY (1999) (0)
Leisure Venue Management (2004) (0)
Prolonged non-invasive ventilatory support prior to pulmonary transplantation does not affect postoperative outcome (2003) (0)
89 Development and external validation of a multivariable model of pre-test likelihood of coronary artery disease based on a contemporary uk population, with comparison to existing risk models (2017) (0)
Incapacity to increase cardiac output determines 6 minute walk distance in chronic thromboembolic pulmonary hypertension (2011) (0)
314: Long-term results of combined heart-lung transplantation: Analysis of 325 first transplants over twenty-two years at a single centre (2007) (0)
Sensitivity analyses: trial-based economic analysis (2014) (0)
Methods for extrapolation from clinical trial data to inform economic evaluations: a taxonomy (2017) (0)
Medical outcomes study Short Form questionnaire-36 items (2014) (0)
The effect of oxygenator choice on hypotension during cardiopulmonary bypass (2011) (0)
An approach for selecting small sets of diagnosis codes with high prediction performance in large datasets of electronic medical records (2020) (0)
Characteristics of the 56 excluded studies (2014) (0)
Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry (2022) (0)
One-year mortality of colorectal cancer patients: development and validation of a prediction model using linked national electronic data (2020) (0)
Abstract 5845: Are Aortic Bioprostheses an Increasingly Good Option in Selected Patients Below the Age of 65? (2008) (0)
Summary of protocol changes (2014) (0)
411: 25 Years of Heart & Lung Transplantation: Past, Present & Future (2010) (0)
219 Right Ventricular Reverse Remodeling after Pulmonary Endarterectomy: Assessment by Magnetic Resonance Imaging (2011) (0)
Incidence of bronchiolitis obliterans syndrome unaffected by absence of cytomegalovirus. (2001) (0)
The UK trial of transmyocardial laser revascularisation Health related quality of life (2000) (0)
Transmyocardial laser revascularisation in clinical practice (1999) (0)
Search strategies for the systematic review (2014) (0)
Incapacity to increase pulmonary blood flow determines 6 minutes walking distance in pulmonary hypertension (2011) (0)
Long-term cost-effectiveness of oral mandibular devices compared with continuous positive airway pressure and conservative management (2014) (0)
Multi-State model with nonparametric discrete frailty (2018) (0)
Delirium Incidence But May Improve Factual Memory Encoding in Cardiac Surgical ICU Patients Aged Over 70 Years: A Pilot Time-Cluster Randomized Controlled Trial. Frontiers in aging (2020) (0)
Differences in quality-adjusted life-years compared with no treatment (2014) (0)
Individual health-care resource use case report form (2014) (0)
S92 Epithelial mesenchymal transition occurs earlier than previously thought in the development of squamous cell carcinoma of the lung (2010) (0)
Linkage of multiple electronic health record datasets using a ‘spine linkage’ approach compared with all ‘pairwise linkages’ (2022) (0)
Abstract 2470: Severe Patient-prosthesis Mismatch Does Not Impair Quality Or Life Or Left Ventricular Mass Regression One-year Following Aortic Valve Replacement. (2007) (0)
European Quality of Life-5 Dimensions 3-level version (2014) (0)
Randomised Surgical Trials: Methods to Improve Recruitment and Study Design. (2012) (0)
Five-year results of Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation (2022) (0)
Effect of prostacyclin infusion as a treatment of pulmonary hypertension (1996) (0)
Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study (2022) (0)
Characteristics of the 71 included studies (2014) (0)
KIDNEYS RETRIEVED FROM DONORS WITH PROLONGED TIME TO ASYSTOLE INCREASE THE ORGAN POOL WITHOUT COMPROMISING DCD OUTCOME: 1850 (2010) (0)
Functional Outcomes of Sleep Questionnaire (2014) (0)
Differences in European Quality of Life-5 Dimensions 3-level version quality-adjusted life-years for each treatment versus control (2014) (0)
Unit costs used and data sources (2014) (0)
TRANSMYOCARDIAL LASER REVASCULARISATION. AUTHORS' REPLY (1999) (0)
Sleep Apnoea Quality of Life Index (2014) (0)
A model of cost-effectiveness and cost-utility of Implantable Cardioverter Defibrillators used for primary prevention in a UK context (2005) (0)
The relationship between knee symptoms and 3D MRI knee bone shape: Data from the Osteoarthritis Initiative (2016) (0)
Incapacity to increase cardiac output determines 6 minute walk distance in pulmonary hypertension (2011) (0)
Multi-state modeling of the hospitalization process of patients affected by Chronic Heart Failure (2013) (0)
Vasopressor dose predicts intrinsic right ventricular dysfunction in the human donor (2002) (0)
Objectives The objectives of this trial were to assess the following : ● acceptability and feasibility of functional tests as a gateway to angiography for the management of coronary artery disease (2007) (0)
Health related quality of life of heart-lung transplant patients (1998) (0)
Abstract 1611: Remote Ischemic Preconditioning Improves 6-month Outcome after Elective Percutaneous Coronary Intervention: A Single-Center Randomized Controlled Trial (2008) (0)
The cost effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: Principal results from the CECaT trial (2007) (0)
Survival Analysis and Censored Data (2020) (0)
MesoTRAP: A feasibility study comparing video-assisted thoracoscopic partial pleurectomy/decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for (2018) (0)
Contrasting principal stratum and hypothetical strategy estimands in multi-period crossover trials with incomplete data. (2022) (0)
Complex Intervention Trials (2020) (0)
Methods for Handling Unobserved Covariates in a Bayesian Update of a Cost-effectiveness Model (2017) (0)
P067 Mechanisms for the effect of CFRD on mortality: a causal mediation analysis using UK cystic fibrosis Registry data (2021) (0)
Can 10m shuttle walk predict Peak VO2 uptake in resectable lung cancer patients. (2006) (0)
THE IMMUNOGENICITY OF HLA DETERMINED AT THE STRUCTURAL AND PHYSIOCHEMICAL LEVEL PREDICTS THE OCCURRENCE AND MAGNITUDE OF HUMORAL IMMUNE RESPONSES TO ALLOANTIGEN AND CORRELATES WITH OUTCOME FOLLOWING DECEASED DONOR KIDNEY TRANSPLANTATION: 1816 (2010) (0)
Bias of complete-case analysis of williams square crossover designs when data are missing not at random (2015) (0)
Linkage of multiple electronic health record datasets using a "spine linkage" approach compared to all "pairwise linkages". (2022) (0)
Response to correspondence regarding 5-year follow up of the Amaze Randomized Controlled trial of ablation treatment for arrhythmia as an adjunct to cardiac surgery. (2022) (0)
- 1-TITLE : Demographics , BMPR 2 status and outcomes in Distal Chronic Thromboembolic Pulmonary Hypertension (2007) (0)
114: Prolonged postoperative mechanical ventilation of more than twenty-four hours (PPMV) following lung transplantation: Incidence, indications and outcomes (2007) (0)
47 Using Natriuretic Peptide Levels to Diagnose Heart Failure in Primary Care: An Evaluation of the 2010 United Kingdom National Institute of Clinical Excellence Guidelines on the Diagnosis of Chronic Heart Failure (2015) (0)
P-34 Who assesses performance status more accurately, patients or their oncologists? (2003) (0)

This paper list is powered by the following services:

Other Resources About Linda Sharples

en.wikipedia.org

What Schools Are Affiliated With Linda Sharples?

Linda Sharples is affiliated with the following schools: